Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia

Blood

Volumn 96, Issue 3, 2000, Pages 1080-1086

  Niitsu, N ^a   Okabe Kado, J ^a   Nakayama, M ^a   Wakimoto, N ^a   Sakashita, A ^a   Maseki, N ^a   Motoyoshi, K ^a   Umeda, M ^a   Honma, Y ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION INDUCING FACTOR; INHIBITOR PROTEIN; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL;

EID: 0034254614     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.3.1080.015k18_1080_1086     Document Type: Article

References (34)

1. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase
2. Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiating mouse myeloid leukemia cells
3. Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells
4. Nm23/ nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions
5. Evidence for a novel gene associated with low tumor metastatic potential
6. Identification of a second nm23 gene, nm23-H2
7. Nucleoside diphosphate kinase from human erythrocytes
8. The human NME2 gene lies within 18kb of NME1 in chromosome 17
9. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2
10. Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe
11. A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require its kinase activity
12. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia
13. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematological malignancies
14. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukemia
15. Prognostic implications of the differentiation inhibitory factor nm23- H1 protein in the plasma of aggressive non-Hodgkin's lymphoma
16. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group
17. Proposals for the classification of the acute leukemias
18. AML-87 Study of the Japan Adult Leukemia Study Group. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia
19. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia
20. Molecular cloning and functional expression of the second mouse nm23/NDP kinase gene, nm23-M2
21. Transferrin binding to K62 cell lines
22. Nonparametric estimation from incomplete observations
23. Individual comparisons by ranking methods
24. Evaluation of survival data and two new rank order statistics arising in its consideration
25. Regression models and life tables
26. Reduced Nm23/Awd protein in tumor metastasis and aberrant Drosophila development
27. Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia
28. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia
29. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia
30. The characteristics and outcome of patients with late relapse acute myelogenous leukemia
31. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
32. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumor aggressiveness
33. Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia
34. Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells